Literature DB >> 19368770

Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs.

M M Harmsen1, H P D Fijten, B Engel, A Dekker, P L Eblé.   

Abstract

We aim to develop a method that confers rapid protection against foot-and-mouth disease (FMD) by passive immunization with recombinant llama single-domain antibody fragments (VHHs). Previously constructed genetic fusions of two VHHs (VHH2s) that either neutralizes FMDV or binds to porcine immunoglobulin to increase the serum half-life, conferred only limited protection to pigs. We therefore now generated VHH3s containing an additional FMDV binding VHH. Two VHH3s neutralized FMDV more potently than single VHHs and were highly produced by yeast cells. Injection of a mixture of these two VHH3s 24h before FMD challenge infection of pigs reduced and delayed the development of clinical disease, viraemia and viral shedding. Furthermore, it significantly (P=0.023) delayed FMD transmission. Thus, we have shown a proof of concept of passive FMD immunoprophylaxis using VHHs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368770     DOI: 10.1016/j.vaccine.2009.01.110

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.

Authors:  Greg Hussack; Mehdi Arbabi-Ghahroudi; Henk van Faassen; J Glenn Songer; Kenneth K-S Ng; Roger MacKenzie; Jamshid Tanha
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

2.  Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Silvia Gómez-Sebastián; Carmen Nuñez; Carmen Alvarado; Rodrigo Lasa; José M Escribano; Lorena L Garaicoechea; Fernando Fernandez; Karin Bok; Andrés Wigdorovitz; Linda J Saif; Viviana Parreño
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

Review 3.  Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Toxins (Basel)       Date:  2010-05-07       Impact factor: 4.546

4.  Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.

Authors:  Sanne Terryn; Aurélie Francart; Sophie Lamoral; Anna Hultberg; Heidi Rommelaere; Angela Wittelsberger; Filip Callewaert; Thomas Stohr; Kris Meerschaert; Ingrid Ottevaere; Catelijne Stortelers; Peter Vanlandschoot; Michael Kalai; Steven Van Gucht
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 5.  Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.

Authors:  Yongzhong Wang; Zhen Fan; Lei Shao; Xiaowei Kong; Xianjuan Hou; Dongrui Tian; Ying Sun; Yazhong Xiao; Li Yu
Journal:  Int J Nanomedicine       Date:  2016-07-21

Review 6.  Trends in recombinant protein use in animal production.

Authors:  Laia Gifre; Anna Arís; Àlex Bach; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2017-03-04       Impact factor: 5.328

7.  Delivery of an anti-transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons.

Authors:  João R Gomes; Inês Cabrito; Hugo R Soares; Susete Costelha; Anabela Teixeira; Angela Wittelsberger; Catelijne Stortelers; Peter Vanlandschoot; Maria J Saraiva
Journal:  J Neurochem       Date:  2018-05-09       Impact factor: 5.372

Review 8.  Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.

Authors:  Pierre Lafaye; Tengfei Li
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2018-09-25       Impact factor: 2.268

9.  Construction and characterization of porcine single-chain fragment variable antibodies that neutralize transmissible gastroenteritis virus in vitro.

Authors:  Fanqing Zhang; Yuxue Chen; Liang Yang; Jianguo Zhu
Journal:  Arch Virol       Date:  2019-02-07       Impact factor: 2.574

Review 10.  Recombinant Antibodies in Veterinary Medicine: An Update.

Authors:  Lorena Bustamante-Córdova; Edgar A Melgoza-González; Jesús Hernández
Journal:  Front Vet Sci       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.